Time and concentration dependency of P-gp, MRP1 and MRP5 induction in response to gemcitabine uptake in Capan-2 pancreatic cancer cells

被引:23
作者
Kohan, Hamed Gilzad [1 ]
Boroujerdi, Mehdi [1 ]
机构
[1] Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Albany, NY 12208 USA
关键词
Capan-2; cells; chemo-resistance; concentration dependency; efflux proteins; gemcitabine; pancreatic cancer; MULTIDRUG-RESISTANCE; NUCLEOSIDE; SENSITIVITY; EXPRESSION; CARCINOMA; LINES; PHARMACOGENOMICS; ADENOCARCINOMA; GLYCOPROTEIN; TRANSPORT;
D O I
10.3109/00498254.2014.1001809
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Influx and efflux proteins play a major role in the overall uptake and efficacy of chemotherapeutic agents and cellular chemo-resistance. 2. The present study investigated the time course and dose dependency of the induction of three efflux proteins, P-gp, MRP1 and MRP5, in response to gemcitabine exposure in Capan-2 pancreatic cancer cell line at transcriptional and translational levels. The influence of exposure on the influx protein (ENT1), the net cellular uptake of the gemcitabine, the overall ATPase activity and the cell death rate were also measured. 3. The time course of the expression exhibited an initial rise, toward a plateau level. The estimated K-m and V-max confirmed that MRP5 and to a lesser extent MRP1 are the prominent proteins for efflux of gemcitabine. Both mRNA and protein expression demonstrated the time and concentration dependency of the induction; and the elevated ATPase activity validated that the induced efflux proteins are functionally active. 4. The results of the study revealed that the efficacy window of gemcitabine as it relates to the function of the efflux proteins is concentration and temporal dependent and is well correlated to the first 60 min of exposure.
引用
收藏
页码:642 / 652
页数:11
相关论文
共 34 条
[1]  
Avellana Patricia, 2007, Rev. argent. cardiol., V75, P55
[2]   Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines [J].
Bergman, AM ;
Pinedo, HM ;
Talianidis, I ;
Veerman, G ;
Loves, WJP ;
van der Wilt, CL ;
Peters, GJ .
BRITISH JOURNAL OF CANCER, 2003, 88 (12) :1963-1970
[3]   Concentration dependency of modulatory effect of amlodipine on P-glycoprotein efflux activity of doxorubicin - a comparison with tamoxifen [J].
Darvari, R ;
Boroujerdi, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (08) :985-991
[4]   Phenotype and Genotype of Pancreatic Cancer Cell Lines [J].
Deer, Emily L. ;
Gonzalez-Hernandez, Jessica ;
Coursen, Jill D. ;
Shea, Jill E. ;
Ngatia, Josephat ;
Scaife, Courtney L. ;
Firpo, Matthew A. ;
Mulvihill, Sean J. .
PANCREAS, 2010, 39 (04) :425-435
[5]   Pancreatic cancer: Clinical presentation, pitfalls and early clues [J].
DiMagno, EP .
ANNALS OF ONCOLOGY, 1999, 10 :140-142
[6]   DIRECT LINEAR PLOT - NEW GRAPHICAL PROCEDURE FOR ESTIMATING ENZYME KINETIC-PARAMETERS [J].
EISENTHAL, R ;
CORNISH-BOWDEN, A .
BIOCHEMICAL JOURNAL, 1974, 139 (03) :715-720
[7]   Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer [J].
El Maalouf, Ghassan ;
Le Tourneau, Christophe ;
Batty, Georges Nicolas ;
Faivre, Sandrine ;
Raymond, Eric .
CANCER TREATMENT REVIEWS, 2009, 35 (02) :167-174
[8]  
García-Manteiga J, 2003, CLIN CANCER RES, V9, P5000
[9]   Proteome survey reveals modularity of the yeast cell machinery [J].
Gavin, AC ;
Aloy, P ;
Grandi, P ;
Krause, R ;
Boesche, M ;
Marzioch, M ;
Rau, C ;
Jensen, LJ ;
Bastuck, S ;
Dümpelfeld, B ;
Edelmann, A ;
Heurtier, MA ;
Hoffman, V ;
Hoefert, C ;
Klein, K ;
Hudak, M ;
Michon, AM ;
Schelder, M ;
Schirle, M ;
Remor, M ;
Rudi, T ;
Hooper, S ;
Bauer, A ;
Bouwmeester, T ;
Casari, G ;
Drewes, G ;
Neubauer, G ;
Rick, JM ;
Kuster, B ;
Bork, P ;
Russell, RB ;
Superti-Furga, G .
NATURE, 2006, 440 (7084) :631-636
[10]  
Gibaldi M., 1982, Pharmacokinetics